Background {#Sec1}
==========

Chronic respiratory disorders contribute significantly to the global burden of disease, the recognition of which prompted their inclusion among the four priorities of the 2008--2013 World Health Organization's action plan on non-communicable diseases \[[@CR1]\]. Chronic obstructive pulmonary disease (COPD) is the 4th leading cause of death, and others such as asthma are increasing in prevalence affecting hundreds of millions at some stage in their lives \[[@CR2]\], while obstructive sleep apnoea (the prevalence of the other type of sleep apnoea, i.e., central sleep apnoea is very low in the population \[[@CR3]--[@CR5]\]) is also a common but under-diagnosed chronic respiratory disorder \[[@CR6]--[@CR8]\]. It is increasingly being recognised as having a significant impact on global burden of disease \[[@CR9]\]. However, the evidence on the prevalence and associations of obstructive sleep apnoea in Australian (and New Zealand) populations are limited \[[@CR10]--[@CR14]\]. A recent study showed that one in ten Australians suffer from undiagnosed obstructive sleep apnoea \[[@CR13]\]; in the males aged 40--69 years this could be as high as 49 % and in males aged \>70 years, as high as 62 % \[[@CR10]\]. It is becoming a major public health concern with its increasing prevalence and complications \[[@CR9], [@CR15]--[@CR18]\].

Most advances in knowledge of obstructive sleep apnoea have taken place only recently \[[@CR19]\]; it is now suggested that it may overlap with other chronic respiratory diseases; a substantial overlap occurs between obstructive sleep apnoea and COPD or asthma \[[@CR20], [@CR21]\]. The prevalence of obstructive sleep apnoea varies in different populations and different age groups, becoming markedly increased in older age \[[@CR22], [@CR23]\]. It is commoner in obese individuals, as well as in those with underlying comorbidities (such as cardiovascular diseases, cerebrovascular diseases, and metabolic abnormalities), people with a family history of obstructive sleep apnoea, and those with anatomically compromised upper airways. Men are more likely to develop obstructive sleep apnoea and the diseases that it complicates \[[@CR9], [@CR17], [@CR23], [@CR24]\]. There is, however, a dearth of evidence on prevalence of obstructive sleep apnoea and its co-morbidities in Australian men.

Using cross-sectional data from the baseline wave of Ten to Men (The Australian Longitudinal Study on Male Health) we aimed to describe the prevalence of self-reported, doctor-/health professional- diagnosed sleep apnoea (hereafter referred to as sleep apnoea) and its overlap with other chronic respiratory diseases, its association with measures of health status and quality of life, and potential correlates among Australian men.

Methods {#Sec2}
=======

Study design and setting {#Sec3}
------------------------

Ten to Men is a longitudinal cohort study of Australian males aged between 10 and 55 years at the time of recruitment (October 2013 to July 2014). Participants were recruited from major cities as well as regional and rural areas. The target population was all Australian male citizens or permanent residents living in private dwellings except those residing in areas classified as remote or very remote.

Sample and sampling process {#Sec4}
---------------------------

We used multi-stage stratified cluster sampling with oversampling of regional areas to increase their representation within the cohort. We approached 104,884 dwellings, of which 32 % met eligibility criteria. Of these, 13,697 (41 %) households returned usable data. Of the 45,510 males confirmed as meeting eligibility criteria, 15,988 (35 %) returned usable data. The setting, design, sampling, study instruments, data collection process, and participants' characteristics of the Ten to Men study is described elsewhere in this issue \[[@CR25]\].

Study instruments {#Sec5}
-----------------

Adult participants answered a self-completed paper-based questionnaire, a copy of which is available at the Ten to Men website \[[@CR26]\]. The questionnaire sought details of the participants' socio-demographic characteristics, physical and mental health status, health-related behaviours, family and social life, and health service use. Wherever possible, the items were from validated scales or questions used in other large health studies.

Data collection {#Sec6}
---------------

Interviewers made up to three attempts (including at least once at a weekend) to contact each household and ascertain the presence of eligible males. A study pack, including consent forms and questionnaires, was left for each eligible individual in a household, which were collected about a week later.

Definitions {#Sec7}
-----------

We defined sleep apnoea as self-reported, doctor-or other health professional- diagnosed sleep apnoea during life. This was based on the question "Has a doctor or other health professional ever told you that you had this condition? (Sleep apnoea)". We used the same question to define the other chronic respiratory diseases (asthma, COPD ("emphysema or chronic obstructive pulmonary disease"), and chronic bronchitis).

Self-rated health was defined using the question "In general, would you say your health is excellent/very good/good/fair/poor" from the Short Form 12 (SF12) \[[@CR27]\]. Cognition was assessed by the response to the question "Do you have difficulty remembering or concentrating?" taken from the Washington Group on Disability Statistics' Short set of Questions on Disability \[[@CR28]\]. We used the items of the SF-12 and Personal Wellbeing Index for Adults (English PWI-A, 4th edition) \[[@CR29]\] to measure participants' physical and mental health and their subjective wellbeing, respectively. Presence/absence of non-respiratory co-morbidities (eczema, diabetes, high cholesterol, high blood pressure, heart attack, heart failure, angina, stroke, depression, post-traumatic stress disorder, other anxiety disorders, schizophrenia, and cancer) was ascertained in the same manner as for sleep apnoea using the same question. As this paper is exploratory in nature, we included all reported cardiovascular, metabolic, respiratory, and hypersensitivity disorders as well as cancer in the analysis of correlates. We used self-reported height and weight to derive body-mass index (BMI). Level of physical activity was assessed using the Active Australia survey \[[@CR30]\] and sitting time by questions on time spent sitting on work and non-work days \[[@CR31]\].

Statistical methods {#Sec8}
-------------------

Stata SE 13.1 (Stata Corp LP, College Station, TX, USA) was used for data analysis. When estimating prevalence, we accounted for the multi-stage sampling, stratification and selection probabilities (including varying response fractions by primary sampling unit) by using Stata's "survey" commands and sampling weights \[[@CR32]\]. For associations between sleep apnoea and other characteristics, no account was taken of the clustering, stratification and sampling weights \[[@CR32]\]. We compared the distribution of other variables among those with and without sleep apnoea using bivariate statistics (*χ* ^2^ test and *t*-test). We used logistic regression to estimate crude odds ratios to measure associations between possible correlates and sleep apnoea, and odds ratios adjusted for the possible confounding effects of age, country of birth, and BMI. Because the prevalence of sleep apnoea was less than 10 %, the prevalence odds ratios are reasonably accurate estimates of prevalence ratios.

Results {#Sec9}
=======

Prevalence of sleep apnoea and overlap with other chronic respiratory disorders {#Sec10}
-------------------------------------------------------------------------------

Of the 13,423 respondents, 710 reported as being diagnosed to have sleep apnoea by a doctor or another health professional. The prevalence of sleep apnoea increased with age from 2.0 % (95 % CI 1.4 %-2.9 %) in those aged 18--25 years to 3.7 % (95 % CI 2.8 %--4.8 %), 6.6 % (95 % CI 5.6 %--7.8 %), and 7.8 % (95 % CI 6.7 %--9.0 %) in those aged 26--35, 36--45, and 46--55 years, respectively. Sleep apnoea without other comorbid chronic respiratory disorders increased from 1.4 % in 18--25 years age-group to 6.1 % in 46--55 years age-group (Fig. [1](#Fig1){ref-type="fig"}). Combination of sleep apnoea and asthma increased from 0.6 % in the youngest to 1.2 % in the oldest age-group. The overlap of sleep apnoea and COPD/chronic bronchitis was relatively low, occurring only in those aged over 35 years. The proportion with sleep apnoea and both above other conditions was also very low (\<0.1 % in all ages). Of those with sleep apnoea, 14.2 % had concurrent asthma but only 0.01 % and 0.02 %, respectively, had concurrent COPD/Chronic bronchitis and both asthma and COPD/Chronic bronchitis.Fig. 1Lifetime prevalence of sleep apnoea and other chronic respiratory diseases adjusted for the sampling design

The impact of sleep apnoea on health and wellbeing {#Sec11}
--------------------------------------------------

Men with doctor-/health professional- diagnosed sleep apnoea were more likely to report fair or poor health status and difficulty in remembering or concentrating than those without sleep apnoea (Table [1](#Tab1){ref-type="table"}). Those with sleep apnoea also had lower SF-12 physical health and mental health summary scores as well as subjective wellbeing scores compared with those without sleep apnoea.Table 1Differences in self-rated health and wellbeing by sleep apnoea statusHealth and wellbeing measureLifetime doctor- or other health professional- diagnosed sleep apnoeaSleep apnoeaNo sleep apnoeaHealthN (% within sleep apnoea category)*p*Self-rated health status Excellent/very good/good524 (74.3 %)11669 (92.0 %)\<0.001^a^ Fair/Poor181 (25.7 %)1009 (8.0 %)Difficulty in remembering or concentrating No difficulty365 (51.8 %)8736 (69.2 %)\<0.001^a^ Some difficulty282 (40.1 %)3485 (27.6 %) A lot of difficulty or cannot do at all57 (8.1 %)409 (3.2 %)Mean (SD)SF-12 Physical Component Score50.0 (9.9)54.2 (7.1)\<0.001^b^SF-12 Mental Component Score46.3 (10.6)50.1 (9.1)\<0.001^b^WellbeingSubjective Wellbeing Score63.6 (19.2)70.8 (16.9)\<0.001^ba^Based on *χ* ^2^ test^b^Based on *t* test

Correlates of sleep apnoea {#Sec12}
--------------------------

Compared with those aged 18--25 years, the association between doctor-/health professional- diagnosed sleep apnoea and age showed a 1.6, 2.4, and 3.1 fold increased odds, respectively, in those aged 26--35, 36--45, and 46--55 years (Table [2](#Tab2){ref-type="table"}). Although being born in an Asian country had significantly lower odds of sleep apnoea in the univariate analysis, this was no longer significant when adjusted for age and BMI. Marital status and level of education were not significantly associated with sleep apnoea. Significantly more men with sleep apnoea (11.0 %) were neither working nor looking for work compared with those without sleep apnoea (5.6 %). Among those who were employed, the number of hours worked and shift work did not significantly differ between sleep apnoea and non-sleep apnoea groups.Table 2Associations between socio-demographic characteristics and sleep apnoeaCharacteristicLifetime doctor- or other health professional- diagnosed sleep apnoeaOdds ratio (95 % CI)*p*Adjusted^a^ Odds ratio (95 % CI)*p*Sleep apnoeaTotalN (%^b^)Age 18--25 years48 (2.2 %)2219 (100.0 %)1.01.0 26--35 years112 (3.6 %)3158 (100.0 %)1.7 (1.2, 2.3)0.0041.6 (1.1, 2.4)0.016 36--45 years246 (6.0 %)4095 (100.0 %)2.9 (2.1, 4.0)\<0.0012.4 (1.6, 3.4)\<0.001 46--55 years304 (7.7 %)3951 (100.0 %)3.8 (2.8, 5.1)\<0.0013.1 (2.1, 4.4)\<0.001Country of birth Australia584 (5.7 %)10258 (100.0 %)1.01.0 New Zealand, Polynesia, Micronesia, or Melanesia23 (4.6 %)503 (100.0 %)0.7 (0.5, 1.2)0.2890.7 (0.5, 1.2)0.193 Central, East, South or South-East Asia35 (3.0 %)1175 (100.0 %)0.5 (0.4, 0.7)\<0.0010.7 (0.5, 1.1)0.098 Middle-East (West Asia) or Africa14 (3.6 %)387 (100.0 %)0.6 (0.4, 1.1)0.0850.8 (0.4, 1.3)0.356 Europe or North America54 (5.3 %)1025 (100.0 %)0.9 (0.7, 1.2)0.5750.8 (0.6, 1.2)0.315 South America, Central America or Caribbean0 (0.0 %)64 (100.0 %)-Marital status Never married121 (3.4 %)3508 (100.0 %)1.01.0 Widowed/divorced/separated63 (7.3 %)865 (100.0 %)2.2 (1.6, 3.0)\<0.0011.2 (0.8, 1.8)0.297 Married/de facto relationship522 (5.8 %)8950 (100.0 %)1.7 (1.4, 2.1)\<0.0011.2 (0.9, 1.5)0.278Highest Educational Level Completed secondary school or less176 (5.4 %)3279 (100.0 %)1.01.0 Tertiary certificate, diploma, trade qualifications or other similar qualifications341 (5.7 %)6020 (100.0 %)1.0 (0.9, 1.3)0.5500.9 (0.8, 1.2)0.513 Graduate or post-graduate149 (4.5 %)3299 (100.0 %)0.8 (0.7, 1.0)0.1121.0 (0.8, 1.3)0.906Employment Status Employed566 (5.0 %)11286 (100.0 %)1.01.0 Unemployed and looking for work58 (5.3 %)1093 (100.0 %)1.1 (0.8, 1.4)0.6741.2 (0.9, 1.7)0.265 Neither working nor looking for work77 (9.9 %)777 (100.0 %)2.1 (1.6, 2.7)\<0.0011.9 (1.5, 2.6)\<0.001Number of hours worked per week Up to 20 h27 (4.0 %)681 (100.0 %)1.001.00 21--40 h205 (4.7 %)4377 (100.0 %)1.2 (0.8, 1.8)0.4051.0 (0.6, 1.5)0.896 More than 40 h257 (5.1 %)5054 (100.0 %)1.3 (0.9, 1.9)0.2071.0 (0.6, 1.5)0.860Main job has night shift No418 (4.9 %)8536 (100.0 %)1.01.0 Yes138 (5.3 %)2595 (100.0 %)1.1 (0.9, 1.3)0.3891.1 (0.8, 1.3)0.611^a^Adjusted for age, country of birth and BMI^b^Row percentages

Those with doctor-/health professional- diagnosed sleep apnoea had significantly higher odds of a number of co-morbidities (Table [3](#Tab3){ref-type="table"}). The means (and standard deviations) of the total number of lifetime chronic respiratory diseases, cardiovascular or metabolic diseases, and psychiatric disorders in those with and without sleep apnoea were 0.4 (0.6) vs 0.3 (0.5), 0.9 (1.2) vs 0.4 (0.7), and 0.8 (1.0) vs 0.3 (0.7), respectively (*p* \< 0.001 for all). Sleep apnoea group had significantly increased odds of all co-morbidities included in univariate analyses (Table [3](#Tab3){ref-type="table"}), and all these associations with the exception of stroke and cancer remained significantly high after adjusting for age, country of birth and BMI. Sleep apnoea was associated with a 4.5 fold increased odds of heart failure and over 2 fold increased odds of psychiatric disorders, heart attack, angina, and diabetes. The association between higher BMI and sleep apnoea remained significant after adjusting for country of birth and age. The strength of this association consistently increased from OR 1.7 in the overweight group to OR 10.3 in the morbidly obese (Obesity III) group.Table 3Associations between self-reported comorbidities and sleep apnoeaCo-morbiditiesLifetime doctor- or other health professional- diagnosed sleep apnoea status\
Mean (SD)OR (95 % CI)*p*Adjusted^a^ OR (95 % CI)*p*Sleep apnoea\
*N* (%^b^)TotalLifetime disease status Eczema103 (7.4 %)1395 (100.0 %)1.5 (1.2, 1.9)\<0.0011.6 (1.3, 2.0)\<0.001 Asthma194 (6.6 %)2944 (100.0 %)1.4 (1.2, 1.6)\<0.0011.3 (1.0, 1.6)0.011 COPD or chronic bronchitis72 (10.5 %)683 (100.0 %)2.3 (1.8, 3.0)\<0.0011.6 (1.2, 2.1)0.002 Diabetes87 (18.2 %)477 (100.0 %)4.4 (3.5, 5.7)\<0.0012.4 (1.8, 3.2)\<0.001 High cholesterol220 (10.0 %)2202 (100.0 %)2.5 (2.1, 2.9)\<0.0011.7 (1.4, 2.1)\<0.001 High blood pressure235 (10.7 %)2197 (100.0 %)2.7 (2.3, 3.2)\<0.0011.6 (1.4, 2.0)\<0.001 Heart attack34 (21.7 %)157 (100.0 %)5.2 (3.5, 7.7)\<0.0012.8 (1.8, 4.4)\<0.001 Heart failure23 (28.8 %)80 (100.0 %)7.6 (4.6, 124)\<0.0014.5 (2.6, 8.0)\<0.001 Angina29 (17.8 %)163 (100.0 %)4.1 (2.7, 6.1)\<0.0012.6 (1.6, 4.1)\<0.001 Stroke13 (15.1 %)86 (100.0 %)3.3 (1.8, 6.0)\<0.0011.9 (0.9, 3.9)0.096 Depression297 (11.3 %)2629 (100.0 %)3.2 (2.8, 3.8)\<0.0012.7 (2.3, 3.2)\<0.001 PTSD63 (14.6 %)433 (100.0 %)3.3 (2.5, 4.4)\<0.0012.6 (1.9, 3.5)\<0.001 Other anxiety disorders183 (11.7 %)1567 (100.0 %)2.9 (2.4, 3.5)\<0.0012.7 (2.2, 3.3)\<0.001 Schizophrenia14 (14.9 %)94 (100.0 %)3.2 (1.8, 5.7)\<0.0012.9 (1.5, 5.7)0.002 Cancer34 (9.3 %)366 (100.0 %)1.9 (1.3, 2.8)\<0.0011.4 (0.9, 1.2)0.092BMI category (kg/m^2^) Normal or underweight (up to 24.9)81 (2.1 %)3910 (100.0 %)1.0 Overweight (25.0--29.9)224 (4.4 %)5062 (100.0 %)2.2 (1.7, 2.8)\<0.0011.7 (1.4, 2.4)\<0.001 Obese 1 (30.0--34.9)167 (8.6 %)1951 (100.0 %)4.4 (3.4, 5.8)\<0.0013.6 (2.7, 4.7)\<0.001 Obese 2(35.0--39.9)93 (15.4 %)606 (100.0 %)8.6 (6.3, 11.7)\<0.0017.0 (5.1, 9.6)\<0.001 Obese 3(\> = 40)58 (20.7 %)280 (100.0 %)12.4 (8.6, 17.8)\<0.00110.3 (7.1, 14.9)\<0.001^a^Adjusted for age, country of birth and BMI^b^Row percentages

Insufficient physical activity and sitting time significantly increased the odds of doctor-/health professional- diagnosed sleep apnoea (Table [4](#Tab4){ref-type="table"}). Each one hour increase in sitting time per day was associated with an increased odds of 1.04 for sleep apnoea (95 % CI 1.02, 1.07; *p* \< 0.001). This odds remained significantly increased after adjusting for age, country of birth and BMI (OR 1.03; 95 % CI 1.005, 1.06; *p* = 0.023). When the average sitting time was dichotomised as less than 6 h vs. 6 h or more \[[@CR33]\], the odds of sleep apnoea for those with more sitting time increased by 1.2 fold. Despite the significantly increased odds of sleep apnoea when being an ex-smoker and a current smoker, the strength of association between sleep apnoea and lifetime smoking exposure showed no discernible pattern across different levels of lifetime smoking exposure (Table [4](#Tab4){ref-type="table"}). The association between sleep apnoea and high alcohol use months was also significant.Table 4Associations of lifestyle factors and health-related behaviour with sleep apnoeaCharacteristicProportion with lifetime sleep apnoea statusOR (95 % CI)*p*Adjusted^a^ OR (95 % CI)*p*Sleep apnoeaTotalLifestyle-related factorsN (%^b^)Level of Physical activity Sufficient352 (4.5 %)7773 (100.0 %)1.01.0 Sedentary/Insufficient304 (7.0 %)4330 (100.0 %)1.6 (1.4, 1.9)\<0.0011.3 (1.1, 1.5)0.006Sitting time  \< 6 h per day277 (4.7 %)5949 (100.0 %)1.01.0  \> = 6 h per day318 (5.7 %)5590 (100.0 %)1.2 (1.0, 1.5)0.0121.2 (1.0, 1.4)0.036Smoking status Never smoked319 (4.3 %)7364 (100.0 %)1.0 Ex-smoker220 (6.8 %)3227 (100.0 %)1.6 1.4, 1.9)\<0.0011.2 (1.0, 1.5)0.021 Currently smoking163 (6.2 %)2636 (100.0 %)1.5 (1.2, 1.8)\<0.0011.4 (1.1, 1.7)0.005Lifetime smoking exposure Never smoked319 (4.3 %)7364 (100.0 %)1.01.0 Up to 5 pack-years74 (4.3 %)1716 (100.0 %)1.0 (0.8, 1.3)0.9711.1 (0.8, 1.4)0.593 6--10 pack-years49 (4.8 %)1014 (100.0 %)1.1 (0.8, 1.5)0.4661.0 (0.7, 1.4)0.971 11--20 pack-years103 (8.0 %)1290 (100.0 %)1.9 (1.5, 2.4)\<0.0011.6 (1.3, 2.1)\<0.001 21--40 pack-years86 (7.6 %)1139 (100.0 %)1.8 (1.4, 2.3)\<0.0011.2 (0.9, 1.6)0.167  \> 40 pack-years47 (13.3 %)354 (100.0 %)3.4 (2.4, 6.7)\<0.0011.9 (1.3, 2.8)0.001Alcohol use months Low (\<8)433 (5.0 %)8660 (100.0 %)1.01.0 Medium (8--15)184 (5.2 %)3515 (100.0 %)1.0 (0.9, 1.2)0.5931.1 (0.9, 1.3)0.291 High (\> = 16)87 (7.6 %)1137 (100.0 %)1.6 (1.2, 2.0)\<0.0011.7 (1.3, 2.2)\<0.001^a^Adjusted for age, country of birth and BMI^b^Row percentages

Discussion {#Sec13}
==========

The estimated population prevalence of doctor-/health professional- diagnosed sleep apnoea among Australian men aged 18--25 years to 46--55 years increased from 2.0 % to 7.8 %. Men with sleep apnoea had poorer mental, physical, and self-rated health as well as low subjective wellbeing and difficulty in concentration or remembering. Presence of thirteen of the fifteen co-morbidities examined were significantly increased with sleep apnoea, as were insufficient physical activity, sitting time, smoking, and high alcohol consumption.

Our study has several limitations. While it was designed to be representative of the Australian male population aged 10--55 years, the response fraction was low. Although the sampling weights we used can account to some extent for non-response, bias is still possible when estimating population prevalence. The 'sleep apnoea' definition we used did not discriminate between obstructive vs. central sleep apnoea. Therefore, it is difficult to compare our findings directly with previous studies that are predominantly on obstructive sleep apnoea. However, as the population prevalence of central sleep apnoea is known to be very low \[[@CR3]--[@CR5]\], our definition is unlikely to have a major effect on our findings. The cross sectional associations identified in our study do not allow any conclusions about causation or temporality. In addition, there is also the possibility that our inability to accurately determine whether the reported doctor-/health professional- diagnosed sleep apnoea is being treated might have introduced a bias we cannot account for as there are some evidence that treatment of obstructive sleep apnoea can help better control some co-morbidities \[[@CR34]--[@CR36]\]. However, we do not expect this to be a major limitation as the determination of both sleep apnoea and the co-morbidities were based on 'ever-having' the disease rather than being a current event. We did not objectively measure sleep apnoea or other co-morbidities, which are likely to have influenced the prevalence estimates as well as the associations between sleep apnoea and co-morbidities. Although we used the variable 'country of birth' as a crude proxy for ethnicity in adjusting the odds ratios for associations, it may not necessarily be a reliable marker of ethnicity. Furthermore, our study also lacked some key indices of sleep apnoea burden such as sleepiness and motor vehicle crashes.

The age-specific prevalence of sleep apnoea in our study is much lower than both the age-specific \[[@CR12], [@CR37], [@CR38]\] and age-standardised \[[@CR13]\] prevalence of obstructive sleep apnoea that has been reported in other previous studies. As some people with sleep apnoea can be asymptomatic, and as only those who are symptomatic would generally seek treatment leading to diagnosis by a health professional, the proportion of health professional-diagnosed sleep apnoea tends to be less than the actual population prevalence at any given time. Therefore, the 'self-reported doctor-/health professional- diagnosed' definition of sleep apnoea used in our study compared with the sleep measurement-based objective definitions used in the above studies is likely to have led to lower estimate in our study, reflecting under-reporting related to under-diagnosis of obstructive sleep apnoea, which has been found by others to be highly prevalent \[[@CR13]\]. The prevalence of 7.8 % among those aged 46--55 years in our study is also lower than 11.2 % reported for previously diagnosed obstructive sleep apnoea in another cohort of Australian men aged \>40 years, likely due to inclusion of comparatively older men in that cohort (including those aged \>70 years) \[[@CR10]\]. Given this gradual increase in the sleep apnoea prevalence with advancing age, it would be important to study the older age groups further to determine the prevalence among them and resulting burden of disease. Studies on prevalence and co-morbidities among females will also provide evidence needed to better plan the possible preventative interventions.

Prevalence of concurrent asthma or COPD among those with doctor-/health professional- diagnosed sleep apnoea was lower in our study than what has been previously reported for those with obstructive sleep apnoea \[[@CR39]--[@CR42]\]. This difference could be explained by the participants in those studies being older than our sample on the average, as most chronic respiratory diseases increase with age \[[@CR43]--[@CR45]\]. Lower prevalence in our study may also be due to possible under-reporting resulting from the use of aforementioned definition for sleep apnoea and other diseases. If this lower prevalence does reflect under-diagnosis, it could indicate an increase in future burden of the disease as sleep apnoea concurrent with asthma or COPD leads to higher morbidity and mortality \[[@CR41], [@CR46]\] and underdiagnosed diseases usually present later with more complications.

Our results confirm the previously reported positive associations between obstructive sleep apnoea and ageing \[[@CR14], [@CR37], [@CR47]--[@CR49]\] and BMI \[[@CR8], [@CR50]--[@CR52]\]. However, our results on the positive association between sleep apnoea and heart failure are in contrast to the recent findings from the Atherosclerosis Risk in the Communities Study and the Sleep Heart Health Study \[[@CR52]\] as well as the Osteoporotic Fractures in Men Study \[[@CR53]\], which showed no association between obstructive sleep apnoea/sleep-disordered breathing and heart failure. Those studies were on older men, and therefore, are not comparable with the younger age distribution in our sample. Other literature, however, suggests that obstructive sleep apnoea is a risk factor for heart failure \[[@CR54]--[@CR56]\] concurring with our findings. It is also possible that some of the reported doctor-/health professional- diagnosed sleep apnoea in our study is central sleep apnoea (rather than obstructive sleep apnoea), which is known to be a consequence of heart failure \[[@CR56]\]. However, 60--78 % of sleep apnoea in heart failure is reported in recent studies to be obstructive sleep apnoea \[[@CR57], [@CR58]\].

The associations we found between sleep apnoea and other co-morbidities also confirm the positive associations of obstructive sleep apnoea which previously have been reported for cardiovascular diseases \[[@CR55], [@CR59]--[@CR63]\], metabolic disorders \[[@CR64]--[@CR68]\], and psychiatric disorders \[[@CR69]--[@CR72]\]. Although the association with schizophrenia (OR 2.9) is difficult to interpret due to the wide confidence interval, the association with depression and anxiety disorders (OR 2.7) are robust and may indicate an impending compound burden on the healthcare system as the prevalence of these latter diseases themselves are high and increasing \[[@CR73]--[@CR77]\].

The association between doctor-/health professional- diagnosed sleep apnoea and stroke in our study, nevertheless, was not significant after adjusting for age, country of birth, and BMI. Even with similar adjustments, the significant association between the obstructive sleep apnoea and stroke had remained in the Sleep Heart Health Study participants \[[@CR78]\]. Participants in that study, however, were aged approximately 50 years or more when this association was assessed. As stroke is more a disease of older ages \[[@CR79]--[@CR81]\], inclusion of younger men in our study as well as inadequate power to detect an association due to the low frequency of stroke would have attenuated its association with sleep apnoea.

Our study also adds to the existing evidence on some putative associations. The previous evidence for the association between smoking and obstructive sleep apnoea has been equivocal, the positive association found by smaller studies \[[@CR82]--[@CR84]\] being disputed by findings of much larger studies \[[@CR85]\]. Overall, the evidence favours a positive association, and our findings confirm this. Similar conflicts of evidence exist with regard to the association between obstructive sleep apnoea and alcohol consumption \[[@CR38], [@CR86]--[@CR89]\], which overall favours a positive association, again concurring with our findings.

Conclusion {#Sec14}
==========

The estimated prevalence of doctor-/health professional- diagnosed sleep apnoea and its associations with cardiovascular, metabolic, respiratory, and psychiatric disorders have important clinical and public health implications for Australia. As men are especially vulnerable to some of the chronic diseases that are associated with sleep apnoea, they represent a relevant group for targeted health interventions. While it is not possible to make any direct causal inferences from our study, it is reasonable to consider modifiable lifestyle-related factors such as smoking, alcohol consumption, level of physical activity and BMI to be potential foci for such interventions. These findings may help inform public health policy and clinical disease screening protocols.
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:   Body-mass index

COPD

:   Chronic obstructive pulmonary disease
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